The Charles Stark Draper Laboratory Inc. has inked a three year partnership with Pfizer to create personalised versions of Draper’s Microphysiological Systems (MPS), for cheaper and more effective preclinical testing.
NanoTemper Technologies Gmbh has scored custom from the UK CRO Domainex Ltd., which is using its MicroScale Thermophoresis technology for speedier, “higher quality clinical candidates”.
Smithers Avanza is granted renewal of full accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC), with “no recommendation for improvements.”
Through the collaboration, Purdue will leverage Exicure’s Spherical Nucleic Acid (SNA)™ technology to discover and develop a treatment for psoriasis, and other diseases.
The Institute claims SNBL USA has committed dozens of violations to the Animal Welfare Act and demands more severe consequences from the US Department of Agriculture.
Acticor Biotech has made a deal with Merck KGaA’s CMO MilliporeSigma to use its Provantage End-to-End services to make its anti-thrombotic antibody fragment ACT-017 for stroke.
Charles River Laboratories has announced an "end-to-end" service offering of CRISPR/Cas9 genome engineering technology, including custom in vivo and in vitro genome editing.
Celgene has made a second investment in a machine learning and simulation platform for applications across drug discovery, clinical development, and commercialization.
Merck KGaA has partnered up with clinical research organisation (CRO) Evotec Ag to serve as a one-stop shop for new target discovery using its gene-editing reagents.
The full accreditation by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International Council is the company’s fourth as it looks to have all of its sites accredited.
Envigo has launched an integrated program of in vitro technologies that help predict the likelihood of compounds causing drug induced livery injury (DILI) as part of its new De-Risking Program.
Researchers in sub-Saharan Africa have developed a plug-and-play lab-on-a-chip - a ‘nontraditional approach’ to a global problem, says AAPS plenary speaker.
CiToxLAB has acquired AccelLAB, a preclinical medical device contract research organization (CRO) as the industry works to align the development of new drugs and medical devices.
Knudra Transgenics has licensed CRISPR-Cas9 genome editing patents from ERS Genomics to turn model organisms into ‘powerful platforms for discovery,’ says CSO.
The NORLUX Neuro-Oncology Laboratory has installed MR Solutions’ preclinical scanner to advance cancer research and translation to clinical applications.
The “double edged sword” of increased regulation is a challenge, but Envigo expects outsourcing to continue as the company looks to diversity its service portfolio.
Envigo has collaborated with InterTek and OCSiAl to develop TUBALL™ single wall carbon nanotubes, which is the first of its kind to complete REACH registration.
ATCC has signed a strategic agreement with the contract research organization (CRO) BioAgilytix as part of its ongoing initiative to provide CRO services.
Almac Group’s Diagnostics business will engage with pharma to validate the link between its immune response assay and checkpoint inhibitor based therapy.
Lovelace Biomedical launched this week as a not-for-profit preclinical contract research organization (CRO) with a business model that will let it “put science first.”
Metrion has invested in new laboratories, equipment, and staff, as part of the company's continued growth strategy to form strategic alliances and add "additional breadth."
Thermo Fisher Scientific has revealed a preemptive pharmacogenomic risk factor screening tool to help increase drug development outcome efficiency and reduce adverse drug reactions.
As part of the company’s continued growth, Charles River’s recent partnership with The Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI) will work to accelerate drug development.
With several systems and process improvement initiatives underway, the growing contract research organization (CRO), Venn Life Sciences, continues to look for earnings enhancing opportunities, says CEO.
Charles River Laboratories has acquired Worcester, MA-based contract research organization (CRO) Agilux Laboratories, further bolstering the company’s early-stage services.
The collaboration combines Plasticell’s cell culture media for creating fat and bone cells in 2-dimensional cell cultures, with CellSpring’s high throughput 3-dimensional screening assays for drug discovery.
Through its acquisition of d3 Medicine, Certara has expanded its Strategic Consulting (CSC) division, which uses a range of methods to support drug development.
More than two months after Britain decided to leave the EU, companies reevaluate the state of business and what comes next, specifically for jobs within the industry.
As stem cell and gene editing technologies become more advanced, researchers are increasingly interested in growing human tissues and organs in animals – but what are the implications of human-animal chimeras?
Metrion Biosciences (Metrion), an ion-channel and drug discovery CRO, has joined a network of partners to evaluate the use of primary human dorsal root ganglion (hDRG) neurons in pain research.
AMRI and the University at Albany’s RNA Institute are partnering to speed the development of new RNA-based therapeutics in an “ideal and first of its kind” collaboration.
